Merit Medical Systems (NASDAQ:MMSI) Updates FY 2025 Earnings Guidance

Merit Medical Systems (NASDAQ:MMSI) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 3.580-3.700 for the period, compared to the consensus EPS estimate of 3.740. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.

Wall Street Analyst Weigh In

MMSI has been the topic of a number of research analyst reports. Barrington Research raised their target price on shares of Merit Medical Systems from $114.00 to $115.00 and gave the company an “outperform” rating in a research note on Wednesday, January 29th. Raymond James boosted their price objective on Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 31st. StockNews.com lowered Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Sunday, November 3rd. Canaccord Genuity Group upped their price target on Merit Medical Systems from $127.00 to $128.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. Finally, Needham & Company LLC raised their price objective on shares of Merit Medical Systems from $109.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, January 29th. Two analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $109.80.

Merit Medical Systems Price Performance

MMSI traded down $1.46 during midday trading on Tuesday, reaching $102.05. 783,463 shares of the company’s stock were exchanged, compared to its average volume of 516,680. Merit Medical Systems has a one year low of $70.70 and a one year high of $111.45. The firm has a market capitalization of $5.95 billion, a price-to-earnings ratio of 50.02, a price-to-earnings-growth ratio of 2.34 and a beta of 0.87. The business has a 50-day simple moving average of $102.66 and a two-hundred day simple moving average of $99.81. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Tuesday, February 25th. The medical instruments supplier reported $0.93 EPS for the quarter, beating the consensus estimate of $0.82 by $0.11. Merit Medical Systems had a return on equity of 15.61% and a net margin of 9.05%. As a group, research analysts predict that Merit Medical Systems will post 3.37 EPS for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.